Alnylam Pharmaceuticals
ALNY
#631
Rank
A$56.10 B
Marketcap
A$420.24
Share price
-1.01%
Change (1 day)
-11.10%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company